Biomarkers

Patients

Is women’s health reaching an inflection point?

A half-day symposium – titled Women’s Health: From Intractable to Investable – was held in London on 11th June, organised by Weatherden.

Oncology

ASCO 2026 reshapes oncology trial design

The American Society of Clinical Oncology 2026 annual meeting showcased how, across tumour types, new cancer therapies are achieving deeper responses, extending survival and increasingly mo

R&D

Beyond proof of concept: Alzheimer’s and the next chapter of...

Research has demonstrated that some individuals at elevated risk of Alzheimer's disease can be identified before symptoms emerge.

R&D

Parkinson's disease affected hands on an elderly man

Parkinson’s disease: Transitioning from symptom control to d...

The Parkinson's disease field is increasingly moving toward biologically defined disease frameworks using molecular biomarkers.

News

Parkinson's charity partners Biognosys on biomarker project

A new R&D project will try to develop assays for LRRK2, a biomarker linked to Parkinson's that has emerged as a major drug target in the disease.

News

Blood test samples held by lab technician

Diagnostics lag is holding back new therapies, says study

Advances in therapeutics are outpacing the development of diagnostics due to policy and payment barriers, holding back effective, targeted care.